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a  b  s  t  r  a  c  t
Aim: To discuss the application of external beam radiotherapy (EBRT) and technetium-
99m-labeled red blood cell scintigraphy (LRBCS) in life-threatening hemoptysis from a
non-malignant condition.
Materials and methods: This case report presents a patient with persistent hemoptysis sec-
ondary to chronic Methicillin-resistant Staphylococcus aureus (MRSA) infection in whom
conventional management failed to localize the site of pulmonary bleeding or to provide
effective therapy.
Results: EBRT was successfully given for life-threatening hemoptysis with improvement in
quality of life for nearly 1 year. LRBCS was used to localize the source of further bleeding
and  facilitate targeted therapy.cell scintigraphy
MRSA pneumonia
Benign
Conclusion: EBRT can be an effective and well-tolerated modality in treating life-threatening
hemoptysis refractory to conventional methods. LRBCS is a non-invasive diagnostic tool that
can be used to detect the source of pulmonary bleeding.
©  2013 Greater Poland Cancer Centre. Published by Elsevier Urban & Partner Sp. z o.o. All1.  Case  studyA 48-year-old woman with a background of childhood asthma
and 30 pack-year smoking history was admitted to hospital
with severe bilateral community acquired MRSA pneumonia
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that progressed to a right upper lobe lung abscess and
empyema. She was treated with intravenous antibiotics but
eventually required de-cortication and right upper lobectomy., Peter MacCallum Cancer Centre, Locked Bag 1, A’Beckett St., VIC
Over the next few years, she experienced recurrent MRSA
pneumonia. Serial chest imaging showed a persistent thick
walled right upper lobe cavity and suggestion of mycetoma.
ed by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
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Fig. 1 – Dose distribution for ﬁrst EBRT course with (a) axial and (b) coronal slices. Prescription was 17.5 Gy in 5 fractions,




































previously reported. The fractionation schedule used for the
ﬁrst EBRT course was based on the series by Falkson et al.3
Hemostasis was not achieved as rapidly as they described,
Fig. 2 – LRBCS of the chest was performed using 1 GBq TcO4
after radiolabeling of autologous red blood cells. The initial
planar images up to 4 h showed no bleeding (images not
shown). At 24 h post injection, planar views showed noight upper lobe bronchial stump.
putum cultures were negative for fungi or mycobacteria.
spergillus precipitins were positive.
Two and a half years after her initial admission, she pre-
ented with large volume hemoptysis. Bronchoscopy showed
 bronchopleural ﬁstula from the right upper lobe bronchial
tump communicating with a blood-ﬁlled chronic cavity. Over
he next 10 months she had recurrent episodes of large volume
emoptysis requiring repeated admissions. Bronchial artery
mbolizations were attempted thrice but failed to identify the
leeding point. She was also deemed unsuitable for further
urgery.
After an episode of massive life-threatening hemopty-
is, palliative external beam radiotherapy (EBRT) was given
sing ﬁve 3.5 Gy fractions, delivered once per week using
nterior–posterior parallel opposed ﬁelds with 6 and 18 MV
hotons (Fig. 1). Her hemoptysis did not settle until the ﬁfth
raction. Over the 11 months post-EBRT, she had infrequent
mall volume hemoptysis and did not require hospital admis-
ion.
After further large hemoptysis, technetium-99m-labeled
ed blood cell scintigraphy (LRBCS) showed the focus of bleed-
ng in the right upper lung zone posteriorly (Fig. 2). High dose
ocal EBRT was planned for 50 Gy in 25 fractions (Fig. 3). How-
ver, after the 19th fraction, she died from a massive bleed
rom the right apical cavity, conﬁrmed on autopsy.
.  Discussion
assive hemoptysis is a life-threatening condition and
equires urgent evaluation and intervention due to the associ-
ted mortality risk.1 Key diagnostic modalities include bron-
hoscopy and CT angiography whilst therapeutic manage-
ent generally involves conservative treatments, bronchial
rtery embolization or surgery.1,2 However, these diagnostic
nd therapeutic measures may fail to localize and control
ntermittent hemoptysis, and other modalities need to be
mployed. This case demonstrates the use of unconventional
iagnostic and treatment modalities in the management of
on-malignant hemoptysis.Firstly, EBRT is commonly used for hemoptysis due to lung
malignancies but is not generally used for benign conditions
due to risk of late effects and secondary malignancy. How-
ever, EBRT has been used for treatment of massive hemoptysis
associated with aspergilloma or mycetoma when conven-
tional treatment modalities have failed.3–5 EBRT for recurrent
hemoptysis secondary to chronic MRSA infection has not beenconvincing abnormality (a). However, SPECT-CT showed
focal red blood cell activity (arrows) in the right upper chest
posterolaterally on (b) maximum intensity projection-MIP,
(c) axial fused images and (d) coronal fused images.
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Fig. 3 – Dose distribution for second EBRT course with (a) axial and (b) coronal views. Dose prescription was planned for









7shaping. GTV encompassed the pulmonary bleeding site as
but this patient had a prolonged period after the initial EBRT
with signiﬁcant improvement in hemoptysis and no hospital
admissions. In contrast, she experienced debilitating hemop-
tysis requiring frequent hospital admissions in the year and
a half prior to EBRT. The exact mechanism of radiotherapy-
induced hemostasis is unclear, but may be related to both
acute and late functional and structural changes in lung vas-
culature following irradiation.3,4 Radiotherapy has been used
for abnormal vascular proliferations such as arteriovenous
malformations, angiomas and gastric antral vascular ecta-
sia. Its efﬁcacy in these conditions may be related to loss
of endothelial cells and prevention of neovascularization.6
Whether this applies to chronically inﬂamed or infected tis-
sues is uncertain.
Secondly, this case shows the advantages of LRBCS in
the localization of non-enteric bleeding. LRBCS is less com-
monly used for pulmonary bleeding and its value in literature
is limited to only a few case reports.7,8 It has several
advantages over conventional diagnostic modalities includ-
ing non-invasiveness, high sensitivity for slow or intermittent
bleeds, high speciﬁcity and avoidance of contrast media.7
Recent introduction of SPECT-CT may improve the value of
this test due to the use of attenuation correction and better
anatomical localization gained from co-registered images. For
this case, although planar (conventional) imaging was nega-
tive, SPECT-CT conﬁrmed a bleeding source. Localization of the
pulmonary hemorrhage allowed targeted EBRT.
3.  Conclusion
EBRT can be an effective treatment option for non-malignant
causes of hemoptysis when other therapeutic modalities fail
or are contraindicated. LRBCS is a valuable but underutilized
tool for localizing pulmonary bleeding and its role needs to be
re-deﬁned in the current era of SPECT-CT.
8tiﬁed on SPECT-CT, allowing focal EBRT.
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